About Nanogen Adavanced Diagnostics S.r.l.
At Nanogen, Inc., the company develop diagnostic products that enable physicians to deliver improved patient care. The company's products allow faster and easier diagnosis, treatment and monitoring of cardiovascular disease and infectious diseases. These products include molecular diagnostic kits and reagents, and rapid test kits, which can be used in urgent care settings or at the point-of-care. Nanogen has pioneered developments in areas involving biomarkers, molecular biology and nanotechnology. The company's business focus is to bring better results to diagnostics and healthcare.
Nanogen Adavanced Diagnostics S.r.l. Frequently Asked Questions (FAQ)
Where is Nanogen Adavanced Diagnostics S.r.l.'s headquarters?
Nanogen Adavanced Diagnostics S.r.l.'s headquarters is located at 10398 Pacific Center Court, San Diego.
Who are Nanogen Adavanced Diagnostics S.r.l.'s competitors?
Competitors of Nanogen Adavanced Diagnostics S.r.l. include BrainScope, Natus Medical, BioIQ, Binx Health, LineaGen Research and 7 more.
Compare Nanogen Adavanced Diagnostics S.r.l. to Competitors
XDx is a molecular diagnostics company focused on the discovery, development and commercialization of non-invasive gene expression testing in the areas of transplant medicine and autoimmunity. Per the company, they have developed a proprietary method of utilizing gene expression in blood that aims to provide a new tool for physicians to manage the care of heart transplant patients. The molecular expression technology developed and implemented by XDx in heart transplant patient management is currently being explored to assist with other diseases that involve the immune system.
Lifelinelab s.r.l. started its activities in April 2003, thanks to the commitment of three managers coming from the ex Diagnostic Division Manufacturing Plant of Alfa Wassermann S.P.A. First step has been to secure raw materials, and equipment for R&D and Manufacturing of products and services in the field of Human in Vitro Diagnostics. nnnnnFirst diagnostic reagents were manufactured, in this site, over 40 years ago, through the bravery and the enterprising spirit of Prof. Balducci ex Managing Director of Virology Laboratory of "Istituto Superiore di Sanitu00e0". First products were based on tissue colture technology included a line of complement fixation antigens. Since then, the company developed methods and products, covering almost all the fields of Human in Vitro Diagnostics, from Clinical Chemistry to Immunochemistry. The mostly developed sector has been that of Infectious Diseases with particular regard to Viral pathologies. Most products have been developed using biological raw materials derived from in house, in vivo or in vitro, productions. Nowadays the company aims to face and develop markets with consolidate and emerging technologies such as Microarrays using a chemistry patented and designed to covalently bind either Protein or Nucleic acids which aims to allow the development of extremely sophisticated analysis in the emerging applications of proteomics and genomics.
NeoDiagnostix is a cancer diagnostics company with a focus on women's health, specifically in the domain of cervical cancer detection. The company's main offering is the Cervical DNA Dtex Test, which identifies irreversible DNA damage to cervical cells as an indicator of potential cancer. This diagnostic tool is primarily utilized by healthcare providers in the medical sector. It is based in Rockville, Maryland.
Forth Photonics is a medical device company that designs, develops, manufactures and markets imaging systems for the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions. Forth Photonics aims to help medical practitioners to improve patient care by incorporating advanced biophotonics and optical molecular imaging technologies to assist in early detection, diagnosis and monitoring.
Hx Diagnostics offers rapid diagnostics for seasonal and emerging infectious diseases.
ViralTest offers molecular-based diagnostics development for niche infectious diseases markets.